Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Black Diamond Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Cambridge, MA, United States

  1. PrincipalsElizabeth BuckCHIEF SCIENTIFIC OFFICERMark A. VellecaPRESIDENT & CEOSergey YurasovCHIEF MEDICAL OFFICERand 4 more
  2. CompanyBlack Diamond Therapeutics, Inc.Cambridge, MA, United States
  3. Phone line+1 (617) 417-5868General business
Request a quote

Black Diamond Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker BDTX) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 7

Chief executive

Mark A. VellecaPRESIDENT & CEO

Chair & board

Ali BehbahaniDirector (Board)
Prakash RamanDirector (Board)
Everyone else on file (4)
Elizabeth BuckCHIEF SCIENTIFIC OFFICER
Sergey YurasovCHIEF MEDICAL OFFICER
Brent Hatzis-SchochOfficer (see SEC filing)
Erika JonesOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Elizabeth Buck — CHIEF SCIENTIFIC OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Mark A. Velleca — PRESIDENT & CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Sergey Yurasov — CHIEF MEDICAL OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Brent Hatzis-Schoch — Officer (see SEC filing)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers